Global Acute Spinal Cord Injury Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1542

Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children. 
The treatment of acute spinal cord injury is dependent on few factors such as age, health, medical history, severity of spinal cord injury, type of spinal cord injury and extent of psychological recovery. The treatment regime of acute spinal cord injury consists of medical management and observation in intensive care unit (ICU), corticosteroids to decrease the swelling, mechanical ventilator, bladder catheter and feeding tube. The treatments available against acute spinal cord injury are anterior cervical discectomy (ACDF), total disc arthroplasty, cervical laminoplasty, posterior aminotomy microdiscectomy, lumbar decompression, lumbar fusion and kyphoplasty.
North America was observed to be the largest market for acute spinal cord injury (SCI) diagnosis and treatment. Increasing awareness and advanced technologies are the major driving factors of this market. Europe was observed to be the second largest market as the region is one of the leading research destinations for neurological diseases diagnosis and treatment. Asia-Pacific and Rest of the World were observed to be the most potential markets for acute spinal cord injuries diagnosis and treatment market.
In 2018, the global Acute Spinal Cord Injury market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Acute Spinal Cord Injury status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Spinal Cord Injury development in United States, Europe and China.

The key players covered in this study
Novartis
Oxygen Biotherapeutics
BioAxone BioSciences
AOSpine International
Neuronax
K-Stemcell
Asterias Biotherapeutics
...

Market segment by Type, the product can be split into
Laboratory Tests
Imaging Tests

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Acute Spinal Cord Injury status, future forecast, growth opportunity, key market and key players.
To present the Acute Spinal Cord Injury development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Spinal Cord Injury are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Spinal Cord Injury Market Size Growth Rate by Type (2014-2025)
1.4.2 Laboratory Tests
1.4.3 Imaging Tests
1.5 Market by Application
1.5.1 Global Acute Spinal Cord Injury Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Acute Spinal Cord Injury Market Size
2.2 Acute Spinal Cord Injury Growth Trends by Regions
2.2.1 Acute Spinal Cord Injury Market Size by Regions (2014-2025)
2.2.2 Acute Spinal Cord Injury Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Acute Spinal Cord Injury Market Size by Manufacturers
3.1.1 Global Acute Spinal Cord Injury Revenue by Manufacturers (2014-2019)
3.1.2 Global Acute Spinal Cord Injury Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Acute Spinal Cord Injury Market Concentration Ratio (CR5 and HHI)
3.2 Acute Spinal Cord Injury Key Players Head office and Area Served
3.3 Key Players Acute Spinal Cord Injury Product/Solution/Service
3.4 Date of Enter into Acute Spinal Cord Injury Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Acute Spinal Cord Injury Market Size by Type (2014-2019)
4.2 Global Acute Spinal Cord Injury Market Size by Application (2014-2019)

5 United States
5.1 United States Acute Spinal Cord Injury Market Size (2014-2019)
5.2 Acute Spinal Cord Injury Key Players in United States
5.3 United States Acute Spinal Cord Injury Market Size by Type
5.4 United States Acute Spinal Cord Injury Market Size by Application

6 Europe
6.1 Europe Acute Spinal Cord Injury Market Size (2014-2019)
6.2 Acute Spinal Cord Injury Key Players in Europe
6.3 Europe Acute Spinal Cord Injury Market Size by Type
6.4 Europe Acute Spinal Cord Injury Market Size by Application

7 China
7.1 China Acute Spinal Cord Injury Market Size (2014-2019)
7.2 Acute Spinal Cord Injury Key Players in China
7.3 China Acute Spinal Cord Injury Market Size by Type
7.4 China Acute Spinal Cord Injury Market Size by Application

8 Japan
8.1 Japan Acute Spinal Cord Injury Market Size (2014-2019)
8.2 Acute Spinal Cord Injury Key Players in Japan
8.3 Japan Acute Spinal Cord Injury Market Size by Type
8.4 Japan Acute Spinal Cord Injury Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Acute Spinal Cord Injury Market Size (2014-2019)
9.2 Acute Spinal Cord Injury Key Players in Southeast Asia
9.3 Southeast Asia Acute Spinal Cord Injury Market Size by Type
9.4 Southeast Asia Acute Spinal Cord Injury Market Size by Application

10 India
10.1 India Acute Spinal Cord Injury Market Size (2014-2019)
10.2 Acute Spinal Cord Injury Key Players in India
10.3 India Acute Spinal Cord Injury Market Size by Type
10.4 India Acute Spinal Cord Injury Market Size by Application

11 Central & South America
11.1 Central & South America Acute Spinal Cord Injury Market Size (2014-2019)
11.2 Acute Spinal Cord Injury Key Players in Central & South America
11.3 Central & South America Acute Spinal Cord Injury Market Size by Type
11.4 Central & South America Acute Spinal Cord Injury Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Spinal Cord Injury Introduction
12.1.4 Novartis Revenue in Acute Spinal Cord Injury Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Oxygen Biotherapeutics
12.2.1 Oxygen Biotherapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Spinal Cord Injury Introduction
12.2.4 Oxygen Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2014-2019)
12.2.5 Oxygen Biotherapeutics Recent Development
12.3 BioAxone BioSciences
12.3.1 BioAxone BioSciences Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Spinal Cord Injury Introduction
12.3.4 BioAxone BioSciences Revenue in Acute Spinal Cord Injury Business (2014-2019)
12.3.5 BioAxone BioSciences Recent Development
12.4 AOSpine International
12.4.1 AOSpine International Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Spinal Cord Injury Introduction
12.4.4 AOSpine International Revenue in Acute Spinal Cord Injury Business (2014-2019)
12.4.5 AOSpine International Recent Development
12.5 Neuronax
12.5.1 Neuronax Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Spinal Cord Injury Introduction
12.5.4 Neuronax Revenue in Acute Spinal Cord Injury Business (2014-2019)
12.5.5 Neuronax Recent Development
12.6 K-Stemcell
12.6.1 K-Stemcell Company Details
12.6.2 Company Description and Business Overview
12.6.3 Acute Spinal Cord Injury Introduction
12.6.4 K-Stemcell Revenue in Acute Spinal Cord Injury Business (2014-2019)
12.6.5 K-Stemcell Recent Development
12.7 Asterias Biotherapeutics
12.7.1 Asterias Biotherapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Acute Spinal Cord Injury Introduction
12.7.4 Asterias Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2014-2019)
12.7.5 Asterias Biotherapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details